Structures of acetylated oleanane-type triterpene saponins, rarasaponins IV, V, and VI, and anti-Hyperlipidemic constituents from the pericarps of sapindus rarak

Chemical and Pharmaceutical Bulletin

Volumn 57, Issue 2, 2009, Pages 198-203

  Asao, Yasunobu ^a   Morikawa, Toshio ^b   Yuanyuan, X I E ^b,c   Okamoto, Masaki ^b   Hamao, Makoto ^a   Matsuda, Hisashi ^a   Muraoka, Osamu ^b   Yuan, Dan ^c   Yoshikawa, Masayuki ^a,b  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b KINKI UNIVERSITY   (Japan)

^c SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Anti hyperlipidemic activity; Rarasaponin; Sapindaceae; Sapindus rarak; Triterpene oligoglycoside

Indexed keywords

ANTILIPEMIC AGENT; HEDERAGENIN 3 O (3,4 DI O ACETYL ALPHA ARABINOPYRANOSYL)(1-3) ALPHA RHAMNOPYRANOSYL(1-2) ALPHA ARABINOPYRANOSIDE; HEDERAGENIN 3 O ALPHA ARABINOPYRANOSYL(1-3) ALPHA RHAMNOPYRANOSYL(1-2) ALPHA ARABINOPYRANOSIDE; MUKUROZIOSIDE IIB; PLANT EXTRACT; RARASAPONIN IV; RARASAPONIN V; RARASAPONIN VI; SAPINDUS RARAK EXTRACT; SAPONIN DERIVATIVE; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG ACETYLATION; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG POTENCY; DRUG STRUCTURE; FAST ATOM BOMBARDMENT MASS SPECTROMETRY; HYPERTRIGLYCERIDEMIA; MALE; MOUSE; NONHUMAN; PERICARP; PROTON NUCLEAR MAGNETIC RESONANCE; SAPINDACEAE; SAPINDUS RARAK; STRUCTURE ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ACETYLATION; ANIMALS; ANTILIPEMIC AGENTS; CARBOHYDRATE CONFORMATION; CARBOHYDRATE SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; HYPERTRIGLYCERIDEMIA; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MOLECULAR SEQUENCE DATA; OLEANOLIC ACID; PLANT BARK; PLANT OILS; SAPINDUS; SAPONINS; SPECTROMETRY, MASS, FAST ATOM BOMBARDMENT; SPECTROPHOTOMETRY, ULTRAVIOLET; TRIGLYCERIDES; TRITERPENES;

EID: 61449114952     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.57.198     Document Type: Article

References (29)

1. Morikawa T., Xie Y., Asao Y., Okamoto M., Yamashita C., Muraoka O., Matsuda H., Pongpiriyadacha Y., Yuan D., Yoshikawa M., Phytochemistry, in press.
2. Yoshikawa M., Morikawa T., Nakano K., Pongpiriyadacha Y., Murakami T., Matsuda H., J Nat. Prod., 65, 1638-1642 (2002).
3. Yoshikawa M., Pongpiriyadacha Y., Kishi A., Kageura T., Wang T., Morikawa T., Matsuda H., Yakugaku Zasshi, 123, 871-880 (2003).
4. Morikawa T., Kishi A., Pongpiriyadacha Y., Matsuda H., Yoshikawa M., J. Nat. Prod., 66, 1191-1196 (2003).
5. Kishi A., Morikawa T., Matsuda H., Yoshikawa M., Chem. Pharm. Bull., 51, 1051-1055 (2003).
6. Matsuda H., Pongpiriyadacha Y., Morikawa T., Ochi M., Yoshikawa M., Eur. J. Pharmacol., 471, 59-67 (2003).
7. Matsuda H., Morikawa T., Managi H., Yoshikawa M., Bioorg. Med. Chem. Lett., 13, 3197-3202 (2003).
8. Matsuda H., Ando S., Morikawa T., Kataoka S., Yoshikawa M., Bioorg. Med. Chem. Lett., 15, 1949-1953 (2005).
9. Ando S., Matsuda H., Morikawa T., Yoshikawa M., Bioorg. Med. Chem., 13, 3289-3294 (2005).
10. Morikawa T., Ando S., Matsuda H., Kataoka S., Muraoka O., Yoshikawa M., Chem. Pharm. Bull., 53, 625-630 (2005).
11. Morikawa T., Matsuda H., Yamaguchi I., Pongpiriyadacha Y., Yoshikawa M., Planta Med., 70, 152-159 (2004).
12. Matsuda H., Ninomiya K., Morikawa T., Yasuda D., Yamaguchi I., Yoshikawa M., Bioorg. Med. Chem. Lett., 18, 2038-2042 (2008).
13. Matsuda H., Tewtrakul S., Morikawa T., Nakamura A., Yoshikawa M.,
14. Bioorg. Med. Chem., 12, 5891-5898 (2004).
15. Matsuda H., Morikawa T., Xu F., Ninomiya K., Yoshikawa M., Planta Med., 70, 1201-1209 (2004).
16. Morikawa T., Xu F., Matsuda H., Yoshikawa M., Chem. Pharm. Bull., 54, 1530-1534 (2006).
17. Matsuda H., Yoshida K., Miyagawa K., Asao Y., Takayama S., Nakashima S., Xu F., Yoshikawa M., Bioorg. Med. Chem., 15, 1539- 1546 (2007).
18. Yoshikawa M., Xu F., Morikawa T., Pongpiriyadacha Y., Nakamura S., Asao Y., Kumahara A., Matsuda H., Chem. Pharm. Bull., 55, 308-316 (2007).
19. Yoshikawa M., Morikawa T., Funakoshi K., Ochi M., Pongpiriyadacha Y., Matsuda H., Heterocycles, 75, 1639-1650 (2008).
20. Morikawa T., Funakoshi K., Ninomiya K., Yasuda D., Miyagawa K., Matsuda H., Yoshikawa M., Chem. Pharm. Bull., 56, 956-962 (2008).
21. Kimata H., Nakashima T., Kokubun S., Nakayama K., Mitoma Y., Ki- tahara T., Yata N., Tanaka O., Chem. Pharm. Bull., 31, 1998-2005 (1983).
22. Kojima K., Zhu X.-B., Ogihara Y., Phytochemistry, 48, 885-888 (1998).
23. 13C-NMR spectra of 1-3 were assigned with the aid of distortionless enhancement by polarization transfer (DEPT), double quantum filter correlation spectroscopy (DQF COSY), heteronuclear multiple quantum coherence (HMQC), and heteronuclear multiple bond connectivity (HMBC) experiments.
24. 1)
25. McNeely W., Benfield P., Drugs, 56, 241-249 (1998).
26. Kasai R., Fujino H., Kuzuki T., Wong W.-H., Goto C., Yata N., Tanaka O., Yasuhara F., Yamaguchi S., Phytochemistry, 25, 871-876 (1986).
27. Yoshikawa M., Morikawa T., Yamamoto K., Kato Y., Nagatomo A., Matsuda H., J. Nat. Prod., 68, 1360-1365 (2005).
28. Ninomiya K., Matsuda H., Shimoda H., Nishida N., Kasajima N., Yoshino T., Morikawa T., Yoshikawa M., Bioorg. Med. Chem. Lett., 14, 1943-1946 (2004).
29. Morikawa T., Li X., Nishida E., Ito Y., Matsuda H., Nakamura S., Mu- raoka O., Yoshikawa M., J. Nat. Prod., 71, 828-835 (2008).